Joshua Liang

Chief Strategy Officer & Board Director

Oversee company operations & strategy; since joining Clover in 2016, raised over RMB 750 million (~US$100 million) in total capital, grew FTE headcount 6x to nearly 200 by early 2020, initiated Clover's first clinical trials in Australia & China and led immuno-oncology R&D programs.

Former investment banker at Centerview Partners in the health...

Roles at Clover Biopharmaceuticals

  • Chief Strategy Officer & Board Director

    Current role

Org chart

Direct reports

No reports


No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.